Actelion

www.actelion.com

Actelion Ltd, founded in December 1997, is a biopharmaceutical company with corporate headquarters in Allschwil/Basel, Switzerland, and almost 1,600 em­ployees worldwide. Actelion focuses on the discovery, development and marketing of innovative medicines to serve highly unmet medical needs and improve or pro­long patients’ lives.

Executed Plan

• 1997 : Creation of the company by 4 founders, including Dr Thomas Widmann (Today Chairman of Vinci Life Sciences)
• 1998-1999 : Venture Capital Financing (including Vinci Capital) of MCHF 56
• 2000 : Product launch of Tracleer®
• Q1 2003 : First profitable quarter after only 5 years of operations
• 2007 : 1’600 employees worldwide, sales of CHF 1.32 billion and EBIT of MCHF 471.4.